Updated Date: Wed, 04 Sep 2024 00:00:00 EDT
Vous n'êtes pas connecté
Ahmedabad, India, 19 July 2024 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval for its New Drug Application (NDA) from the United States Food and Drug...
Updated Date: Wed, 04 Sep 2024 00:00:00 EDT
Updated Date: Wed, 04 Sep 2024 00:00:00 EDT
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....
KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...
Updated Date: Thu, 29 Aug 2024 00:00:00 EDT
Updated Date: Fri, 06 Sep 2024 00:00:00 EDT
Updated Date: Fri, 06 Sep 2024 00:00:00 EDT
EBR Systems has submitted the final premarket approval (PMA) application module to the US Food and Drug Administration (FDA) for ...
Updated Date: Fri, 30 Aug 2024 00:00:00 EDT
Updated Date: Mon, 26 Aug 2024 00:00:00 EDT